Chembond Material Technologies Consolidated Net Profit Surges 43.5% to ₹572.6 Lakh in Q1 FY27; Revenue Tops ₹7,200 Lakh

Chembond Material Technologies Limited (formerly known as Chembond Chemicals Limited) has announced its unaudited consolidated financial results for the first quarter ended June 30, 2026 (Q1 FY27). The specialty player clocked a resilient performance characterized by double-digit expansion in top-line operations alongside a substantial surge in bottom-line net profit, driven by operational efficiencies and reduced net tax outgo.

Strong Top-Line Trajectory and Earnings Expansion

For the quarter ended June 30, 2026, Chembond Material Technologies reported a 25.6% year-on-year increase in its consolidated revenue from operations, which rose to ₹7,241.56 lakh compared to ₹5,767.50 lakh in the corresponding quarter of the previous fiscal year (Q1 FY26). On a sequential basis, revenue scaled up modestly from the ₹7,175.37 lakh registered in the fourth quarter ended March 31, 2026 (Q4 FY26).

Supported by other income of ₹376.55 lakh-a sharp recovery from a negative base of ₹(166.30) lakh in Q4 FY26-the company's total income for the quarter stood at ₹7,618.11 lakh, up 26.3% over the ₹6,032.64 lakh logged in the parallel prior year quarter.

The company's bottom-line performance displayed remarkable strength:

Net Profit After Tax (PAT): Grew by 43.5% year-on-year to hit ₹572.62 lakh, up from ₹399.02 lakh in Q1 FY26. On a sequential basis, net earnings surged by 64.3% from the ₹348.48 lakh recorded in Q4 FY26.

Earnings Per Share (EPS): Basic and diluted EPS (face value of ₹5 each, not annualised) expanded to ₹4.26 for the quarter, compared to ₹2.97 in the same quarter last year and ₹2.59 in the preceding quarter.

Total Comprehensive Income: Factoring in net other comprehensive income, total comprehensive income for the period finished at ₹578.30 lakh, compared to ₹400.05 lakh in Q1 FY26.

Expenditure Breakdown and Operational Dynamics

Total expenditures incurred during the quarter stood at ₹7,035.12 lakh, representing an increase from the ₹5,496.12 lakh registered in Q1 FY26, in tandem with accelerated output. The key cost heads included:

Raw Materials: The cost of materials consumed formed the largest expenditure block at ₹4,686.66 lakh, rising from ₹3,312.31 lakh in the corresponding base quarter.

Inventory Shifts: The changes in inventories of finished goods, work-in-progress, and stock-in-trade stood at a negative ₹(95.81) lakh, reflecting strong off-take and standard utilization compared to a positive position of ₹86.53 lakh in Q1 FY26.

Employee Outlays: Employee benefit expenses increased to ₹1,101.80 lakh from ₹923.83 lakh in the previous year's parallel quarter.

Finance and Overheads: Finance costs were kept optimally low at ₹6.15 lakh, demonstrating minimal long-term debt drag. Other operational expenses stood at ₹1,251.45 lakh, while depreciation and amortization charges were recorded at ₹84.86 lakh.

Consolidated profit before exceptional items and tax finished at ₹582.99 lakh. No exceptional items were accounted for during the quarter, locking in the profit before tax at the identical level of ₹582.99 lakh. Net tax expenses for the period dropped significantly to ₹10.37 lakh, buoyed by a deferred tax credit of ₹(69.86) lakh which offset a current tax outgo of ₹80.23 lakh.

Segment Performance: Specialty Chemicals Dominates Top-Line

Chembond Material Technologies' core business lines demonstrated balanced segment progress, with the specialty chemicals unit serving as the primary revenue generator.

Specialty Chemicals Segment: This vertical generated a revenue of ₹6,205.48 lakh during Q1 FY27, up 29.1% year-on-year against the ₹4,805.99 lakh registered in Q1 FY26. The segment's profit before interest and tax (PBIT) stood at ₹100.88 lakh. Total assets deployed in this segment grew to ₹20,716.37 lakh.

Animal Health Segment: The business segment recorded a turnover of ₹1,036.08 lakh, growing 7.8% year-on-year from ₹961.51 lakh in the corresponding period of the prior fiscal. PBIT for Animal Health stood strong at ₹105.57 lakh. Total assets for this division came in at ₹1,487.18 lakh.

As of June 30, 2026, the aggregate consolidated asset footprint of the group climbed to ₹22,203.55 lakh compared to ₹21,942.02 lakh as of March 31, 2026. Conversely, total liabilities were optimized downward during the quarter, dropping from ₹5,247.91 lakh at the end of fiscal 2026 to ₹4,929.14 lakh at the close of Q1 FY27. The company's paid-up equity share capital stood unchanged at ₹672.41 lakh.

Shares of Chembond Material Technologies Limited was last trading in BSE at Rs. 180.50 as compared to the previous close of Rs. 172.70. The total number of shares traded during the day was 245 in over 4 trades.

The stock hit an intraday high of Rs. 180.50 and intraday low of 172.20. The net turnover during the day was Rs. 42461.00.

Source : Equity Bulls

Keywords

ChembondMaterialTechnologies INE995D01025 SpecialtyChemicals Q1FY27 Q1FY2027 ResultUpdate